Yield10 Bioscience, Inc. (YTENQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 6, 2025, 3:27 PM EST
Yield10 Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.73 | 1.07 | 2.36 | 5.33 | 3.42 | 5.42 |
Short-Term Investments | - | - | 1.99 | 10.66 | 6.28 | 5.7 |
Cash & Short-Term Investments | 0.73 | 1.07 | 4.35 | 15.99 | 9.7 | 11.12 |
Cash Growth | -68.62% | -75.43% | -72.81% | 64.81% | -12.73% | 92.70% |
Receivables | - | - | 0.03 | 0.2 | 0.11 | 0.09 |
Prepaid Expenses | 0.47 | 0.33 | 0.64 | 0.44 | 0.53 | 0.48 |
Total Current Assets | 1.2 | 1.4 | 5.02 | 16.62 | 10.34 | 11.68 |
Property, Plant & Equipment | 1.73 | 2.2 | 2.74 | 3.24 | 3.63 | 4.38 |
Other Long-Term Assets | 0.04 | 0.31 | 0.33 | 0.55 | 0.55 | 0.65 |
Total Assets | 2.97 | 3.91 | 8.09 | 20.42 | 14.52 | 16.72 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 2.37 | 1.2 | 0.11 | 0.08 | 0.06 | 0.28 |
Accrued Expenses | 1.56 | 2.01 | 0.93 | 1.14 | 1.3 | 1.33 |
Short-Term Debt | 1 | 0.98 | - | - | - | - |
Current Portion of Leases | 0.68 | 0.67 | 0.58 | 0.51 | 0.46 | 0.6 |
Current Unearned Revenue | 1.8 | - | - | - | - | - |
Other Current Liabilities | 0.27 | - | - | - | - | - |
Total Current Liabilities | 7.67 | 4.87 | 1.61 | 1.73 | 1.81 | 2.21 |
Long-Term Leases | 1.09 | 1.53 | 2.08 | 2.66 | 3.16 | 3.62 |
Other Long-Term Liabilities | - | - | - | - | 0.01 | 14.98 |
Total Liabilities | 9.21 | 6.39 | 3.69 | 4.39 | 4.99 | 20.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 0.01 | 0.12 | 0.05 | 0.05 | 0.03 | 0.01 |
Additional Paid-In Capital | 413.88 | 411.81 | 404.28 | 402.28 | 384.76 | 360.93 |
Retained Earnings | -419.86 | -414.15 | -399.7 | -386.13 | -375.1 | -364.89 |
Comprehensive Income & Other | -0.26 | -0.27 | -0.23 | -0.18 | -0.16 | -0.13 |
Total Common Equity | -6.24 | -2.48 | 4.4 | 16.03 | 9.53 | -4.09 |
Shareholders' Equity | -6.24 | -2.48 | 4.4 | 16.03 | 9.53 | -4.09 |
Total Liabilities & Equity | 2.97 | 3.91 | 8.09 | 20.42 | 14.52 | 16.72 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 2.76 | 3.18 | 2.65 | 3.17 | 3.62 | 4.22 |
Net Cash (Debt) | -2.03 | -2.11 | 1.7 | 12.82 | 6.08 | 6.9 |
Net Cash Growth | - | - | -86.76% | 110.79% | -11.80% | - |
Net Cash Per Share | -3.98 | -6.37 | 8.29 | 65.02 | 61.51 | 453.48 |
Filing Date Shares Outstanding | 0.66 | 0.64 | 0.21 | 0.2 | 0.2 | 0.08 |
Total Common Shares Outstanding | 0.64 | 0.5 | 0.21 | 0.2 | 0.14 | 0.04 |
Working Capital | -6.47 | -3.47 | 3.41 | 14.89 | 8.53 | 9.48 |
Book Value Per Share | -9.71 | -4.95 | 21.36 | 78.79 | 68.62 | -105.03 |
Tangible Book Value | -6.24 | -2.48 | 4.4 | 16.03 | 9.53 | -4.09 |
Tangible Book Value Per Share | -9.71 | -4.95 | 21.36 | 78.79 | 68.62 | -105.03 |
Machinery | - | 0.61 | 0.59 | 0.62 | 0.81 | 0.97 |
Leasehold Improvements | - | 1.44 | 1.43 | 1.42 | 1.41 | 1.75 |